 |
|
Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
Yiwen Zhang, Liwei Wu, Zepeng Mu, Linlin Ren, Ying Chen, Hanyun Liu, Lili Xu, Yangang Wang, Yaxing Wang, Susan Cheng, Yih Chung Tham, Bin Sheng, Tien Yin Wong, Hongwei Ji
Clin Mol Hepatol. 2024;30(1):113-117. Published online 2023 Nov 10 DOI: https://doi.org/10.3350/cmh.2023.0440
|
|
Citations to this article as recorded by
 Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care
Nicola Pugliese, Arianna Bertazzoni, Cesare Hassan, Jörn M. Schattenberg, Alessio Aghemo
Cancers.2025; 17(5): 722. CrossRef Large language models in thyroid diseases: Opportunities and challenges
Yiwen Zhang, Pengfei Li, Lili Xu, Xuejuan Zhang, Hongwei Ji, Yangang Wang
EngMedicine.2025; 2(2): 100076. CrossRef Preliminary fatty liver disease grading using general-purpose online large language models: ChatGPT-4 or Bard?
Yiwen Zhang, Hanyun Liu, Bin Sheng, Yih Chung Tham, Hongwei Ji
Journal of Hepatology.2024; 80(6): e279. CrossRef The performance of large language model-powered chatbots compared to oncology physicians on colorectal cancer queries
Shan Zhou, Xiao Luo, Chan Chen, Hong Jiang, Chun Yang, Guanghui Ran, Juan Yu, Chengliang Yin
International Journal of Surgery.2024; 110(10): 6509. CrossRef
|